Cutia Therapeutics (HKG:2487)

Cutia Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	151.41	265.01	385.67	473.12	465.87	203.13
Short-Term Investments	51.05	91.75	10.53	330.19	567.15	769.65
Trading Asset Securities	423.46	431.49	479.96	469.34	43.5	405.49
Cash & Short-Term Investments	625.91	788.24	876.16	1,273	1,077	1,378
Cash Growth	-8.16%	-10.03%	-31.16%	18.22%	-21.89%	-
Accounts Receivable	146.67	183.3	100.53	63.5	1.34	0.5
Other Receivables	-	17.02	4.22	13.47	2.78	0
Receivables	146.67	200.32	104.75	76.97	4.12	0.5
Inventory	15.15	35.46	74.69	45.31	20	1.8
Restricted Cash	0.59	0.59	-	-	-	-
Other Current Assets	33.76	18.04	31.53	21.38	44.8	21.15
Total Current Assets	822.08	1,043	1,087	1,416	1,145	1,402
Property, Plant & Equipment	187.27	204.81	220.93	226.01	229.01	50.79
Other Intangible Assets	7.09	8.14	8.9	7.81	0.6	0.22
Long-Term Accounts Receivable	36.2	7.18	8.61	9.97	11.27	4.03
Other Long-Term Assets	21.55	8.78	34.41	14.95	30.23	26.86
Total Assets	1,074	1,306	1,393	1,707	1,447	1,495

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.36	15.36	12.82	20.29	-	0.34
Accrued Expenses	27.63	22.21	32.96	34.84	17.88	12.19
Short-Term Debt	-	97.88	173.3	89.41	-	-
Current Portion of Long-Term Debt	122.92	68.76	40	40	-	-
Current Portion of Leases	17	15.56	12.38	11.37	8.83	3.72
Current Income Taxes Payable	0.55	7.22	6.57	1.34	0.96	0.63
Current Unearned Revenue	-	-	-	0.4	-	-
Other Current Liabilities	42.91	42.73	45.23	57.13	49.73	2.39
Total Current Liabilities	213.36	269.72	323.25	254.79	77.4	19.25
Long-Term Debt	88.3	84.57	50	60	2,570	2,243
Long-Term Leases	46.01	50.63	45.26	42.97	45.3	22.82
Long-Term Unearned Revenue	14.88	16.09	-	-	0.4	0.4
Total Liabilities	362.55	421	418.51	357.76	2,693	2,285

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.05	0.05	0.05	0.04	0.01	0.01
Additional Paid-In Capital	-	4,916	4,691	4,686	259.16	259.16
Retained Earnings	-	-3,724	-3,384	-2,950	-986.11	-430.28
Treasury Stock	-13.86	-13.86	-13.86	-	-	-
Comprehensive Income & Other	725.44	-292.62	-318.41	-387.02	-519.37	-619.4
Shareholders' Equity	711.63	885.28	974.73	1,349	-1,246	-790.51
Total Liabilities & Equity	1,074	1,306	1,393	1,707	1,447	1,495

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	274.22	317.39	320.94	243.76	2,624	2,269
Net Cash (Debt)	351.69	470.85	555.22	1,029	-1,548	-891.19
Net Cash Growth	-10.08%	-15.20%	-46.04%	-	-	-
Net Cash Per Share	1.00	1.42	1.81	5.03	-19.33	-11.13
Filing Date Shares Outstanding	363.37	363.37	318.59	304.02	80.05	80.05
Total Common Shares Outstanding	363.37	363.37	318.59	304.02	80.05	80.05
Working Capital	608.72	772.94	763.87	1,162	1,068	1,382
Book Value Per Share	1.96	2.44	3.06	4.44	-15.57	-9.88
Tangible Book Value	704.55	877.15	965.84	1,341	-1,247	-790.73
Tangible Book Value Per Share	1.94	2.41	3.03	4.41	-15.58	-9.88
Machinery	-	102.25	89.89	74.31	52.9	19.38
Construction In Progress	-	-	3.11	2.48	7.23	0.03
Leasehold Improvements	-	160.09	156.31	148.69	136.38	13.16

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 20, 2026

Data Sources Report a data error